{"schema_version":"secwatch.filing_event.v1","accession":"0001360604-23-000044","form_type":"8-K","ticker":"HR","cik":"0001360604","company_name":"Healthcare Realty Trust Inc","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.561234+00:00","generated_at":"2026-06-15T08:35:42.189734+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Healthcare Realty Trust Q1 net loss $87.1M, Normalized FFO $0.40 per share","bullets":["Net loss attributable to common stockholders of $87.1M ($0.23 diluted); Normalized FFO of $152.8M ($0.40).","Same-store cash NOI increased 2.8% YoY; occupancy up 50 bps to 89.0%.","YTD asset sales and JV transactions totaled $208.8M at 6.5% cap rate; $96M closed since January.","Reserved $2.4M revenue on Legacy HTA assets; recorded $5.2M credit loss allowance on mezzanine loan.","Dividend maintained at $0.31 per share; payable June 2, 2023 to holders of record May 16."],"urls":{"canonical":"https://secwatch.observer/filing/0001360604-23-000044","json":"https://secwatch.observer/filing/0001360604-23-000044.json","markdown":"https://secwatch.observer/filing/0001360604-23-000044.md","text":"https://secwatch.observer/filing/0001360604-23-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000044/0001360604-23-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000044/hr-20230509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T08:35:42.189734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29d9f3b9d3dcdb6b7a3090e85ffa0ad1df3bec58","claim":"Healthcare Realty Trust Inc reported the first quarter ended March 31, 2023 results: net income $87.1 million, EPS $0.23 per diluted common share.","evidence_excerpt":"The Company reported net loss attributable to common stockholders of $87.1 million, or $0.23 per diluted common share, for the quarter ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000044/0001360604-23-000044-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Net income","value":"$87.1 million"},{"label":"EPS","value":"$0.23 per diluted common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}